Survival data from patients with advanced or metastatic renal cell carcinoma in routine practice differs significantly from clinical trial data – Analyses from the German clinical RCC Registry.

Marschner, N., Müller, L., Staehler, M., Nusch, A., Münz, M., Koska, M., Jänicke, M., Goebell, P., 2015.

Oncol Res Treat 38 (suppl.5)(V674), 204. doi:10.1159/000439070

Studie: TNK; Indikation: Nierenzellkarzinom; Jahr: 2015; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0